Literature DB >> 15138869

[Neurological complications and loss of efficacy with intrathecal pain therapy].

D Kindler1, C Maier, T Kagel, S Schulz, T Weiss, M Zenz.   

Abstract

In a new guideline issued by the German Association for the Study of Pain, intrathecal opioid therapy is described as proven to be effective with relatively few side effects. We reviewed this statement by analysis of the available literature and critical evaluation of the clinical course in a few of our own patients (n=3). In these cases (as well as in a further eight patients), explantation and a switch to oral opioids led to distinctly better alleviation of pain and abatement of the unwanted effects. The problems we discuss do not appear to be rare instances, but by all means complications that are frequently described. The long-term efficacy of intrathecal opioids has not been adequately verified; moreover, their potency is not high. The frequency of undesired events is comparable to that of oral opioid medication, but serious neurological complications are possible. To avoid dose escalations and to recognize neurological complications in time, diligent monitoring by the surgeon or an experienced pain center is essential.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15138869     DOI: 10.1007/s00482-004-0327-1

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  42 in total

Review 1.  Long-term spinal analgesic delivery: a review of the preclinical and clinical literature.

Authors:  M Wallace; T L Yaksh
Journal:  Reg Anesth Pain Med       Date:  2000 Mar-Apr       Impact factor: 6.288

2.  Cranial nerve palsy and intracranial subdural hematoma following implantation of intrathecal drug delivery device.

Authors:  C A Velarde; R E Zuniga; R F Leon; S E Abram
Journal:  Reg Anesth Pain Med       Date:  2000 Jan-Feb       Impact factor: 6.288

3.  [Guidelines -- safety net].

Authors:  Ch Maier; M Zenz
Journal:  Schmerz       Date:  2003-01       Impact factor: 1.107

4.  Complications of intrathecal baclofen delivery.

Authors:  P Teddy; A Jamous; B Gardner; D Wang; J Silver
Journal:  Br J Neurosurg       Date:  1992       Impact factor: 1.596

Review 5.  Clinical realities and economic considerations: efficacy of intrathecal pain therapy.

Authors:  J A Paice; W Winkelmüller; K Burchiel; G B Racz; J P Prager
Journal:  J Pain Symptom Manage       Date:  1997-09       Impact factor: 3.612

6.  Catheter systems for intrathecal drug delivery.

Authors:  R D Penn; M M York; J A Paice
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

7.  Staphylococcal meningitis following Synchromed intrathecal pump implant: a case report.

Authors:  M I Bennett; Y M Tai; J M Symonds
Journal:  Pain       Date:  1994-02       Impact factor: 6.961

8.  Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology.

Authors:  M Winkelmüller; W Winkelmüller
Journal:  J Neurosurg       Date:  1996-09       Impact factor: 5.115

9.  [Morphine tablets for chronic non-tumor-induced pain. Which factors modify the success or failure of a long-term therapy?].

Authors:  S Schulzeck; M Gleim; C Maier
Journal:  Anaesthesist       Date:  1993-08       Impact factor: 1.041

Review 10.  Spinal drug delivery.

Authors:  T S Grabow; D Derdzinski; P S Staats
Journal:  Curr Pain Headache Rep       Date:  2001-12
View more
  6 in total

1.  [Perispinal pain therapy. How invasive should we be?].

Authors:  F Elsner; L Radbruch
Journal:  Schmerz       Date:  2007-02       Impact factor: 1.107

2.  [Risk minimization in pain therapy: important target but how can it be reached?].

Authors:  G-G Hanekop; F B M Ensink
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

3.  [Addition is also a disease].

Authors:  C Maier
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

Review 4.  [Selected interventional methods for the treatment of chronic pain : part 2: regional anesthetic techniques close to the spinal cord and neuromodulative methods].

Authors:  E Böttger; K Diehlmann
Journal:  Anaesthesist       Date:  2011-06       Impact factor: 1.041

5.  [Dependency syndrome and hyperalgesia due to an opioid therapy for curative treatable pain. Case report of an apparent palliative patient].

Authors:  B Michel-Lauter; K Bernardy; A Schwarzer; V Nicolas; C Maier
Journal:  Schmerz       Date:  2013-09       Impact factor: 1.107

6.  [Accidental levomethadone intoxication in a palliative patient].

Authors:  B Michel-Lauter; C Maier; A Schwarzer
Journal:  Schmerz       Date:  2012-12       Impact factor: 1.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.